Isavuconazole Completed Phase 3 Trials for Invasive Fungal Infections / Aspergillosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00634049Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
NCT00412893Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis